The 36-month beta value for BDSX is at 0.98. Analysts have varying views on the stock, with 4 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for BDSX is 69.40M, and currently, shorts hold a 3.58% of that float. The average trading volume for BDSX on June 03, 2025 was 8.25M shares.
BDSX) stock’s latest price update
The stock of Biodesix Inc (NASDAQ: BDSX) has decreased by -1.00 when compared to last closing price of 0.31.Despite this, the company has seen a loss of -11.46% in its stock price over the last five trading days. globenewswire.com reported 2025-05-22 that LOUISVILLE, Colo., May 22, 2025 (GLOBE NEWSWIRE) — Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostic solutions company, announced today that new data will be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois at 2:30 pm ET on Saturday, May 31st.
BDSX’s Market Performance
BDSX’s stock has fallen by -11.46% in the past week, with a monthly drop of -40.79% and a quarterly drop of -57.40%. The volatility ratio for the week is 4.49% while the volatility levels for the last 30 days are 17.16% for Biodesix Inc The simple moving average for the last 20 days is -7.76% for BDSX’s stock, with a simple moving average of -73.19% for the last 200 days.
Analysts’ Opinion of BDSX
Craig Hallum gave a rating of “Buy” to BDSX, setting the target price at $3 in the report published on July 26th of the previous year.
BDSX Trading at -36.87% from the 50-Day Moving Average
After a stumble in the market that brought BDSX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.97% of loss for the given period.
#####
#####
Insider Trading
Reports are indicating that there were more than several insider trading activities at BDSX starting from SCHULER JACK W, who purchase 4,000,000 shares at the price of $0.27 back on May 16 ’25. After this action, SCHULER JACK W now owns 20,194,935 shares of Biodesix Inc, valued at $1,070,000 using the latest closing price.
SCHULER JACK W, the Director of Biodesix Inc, purchase 723,239 shares at $0.34 during a trade that took place back on May 19 ’25, which means that SCHULER JACK W is holding 20,918,174 shares at $246,624 based on the most recent closing price.
Stock Fundamentals for BDSX
Current profitability levels for the company are sitting at:
- -0.44 for the present operating margin
- 0.78 for the gross margin
The net margin for Biodesix Inc stands at -0.54. The total capital return value is set at -0.45. Equity return is now at value -1454.41, with -46.61 for asset returns.
Based on Biodesix Inc (BDSX), the company’s capital structure generated 0.85 points at debt to capital in total, while cash flow to debt ratio is standing at -0.67. The debt to equity ratio resting at 5.63. The interest coverage ratio of the stock is -4.39.
Currently, EBITDA for the company is -29.22 million with net debt to EBITDA at -1.63. When we switch over and look at the enterprise to sales, we see a ratio of 1.2. The receivables turnover for the company is 9.75for trailing twelve months and the total asset turnover is 0.86. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.22.
Conclusion
In conclusion, Biodesix Inc (BDSX) has had a bad performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
